HYAT PHARMA LTD

Company Registration Number:
11982070 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2024

Period of accounts

Start date: 01 June 2023

End date: 31 May 2024

HYAT PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 May 2024

Balance sheet
Notes

HYAT PHARMA LTD

Balance sheet

As at 31 May 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 902,917 957,917
Tangible assets: 4 1,582 947
Total fixed assets: 904,499 958,864
Current assets
Stocks: 66,564 65,428
Debtors:   22,607 251,315
Cash at bank and in hand: 67,463 31,172
Total current assets: 156,634 347,915
Creditors: amounts falling due within one year: 5 (309,459) (543,274)
Net current assets (liabilities): (152,825) (195,359)
Total assets less current liabilities: 751,674 763,505
Creditors: amounts falling due after more than one year: 6 (681,337) (727,381)
Total net assets (liabilities): 70,337 36,124
Capital and reserves
Called up share capital: 200 200
Profit and loss account: 70,137 35,924
Shareholders funds: 70,337 36,124

The notes form part of these financial statements

HYAT PHARMA LTD

Balance sheet statements

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 January 2025
and signed on behalf of the board by:

Name: Mr Naser Mustafa El-Zebdeh
Status: Director

The notes form part of these financial statements

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

2. Employees

2024 2023
Average number of employees during the period 10 10

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

3. Intangible Assets

Total
Cost £
At 01 June 2023 1,100,000
At 31 May 2024 1,100,000
Amortisation
At 01 June 2023 142,083
Charge for year 55,000
At 31 May 2024 197,083
Net book value
At 31 May 2024 902,917
At 31 May 2023 957,917

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

4. Tangible Assets

Total
Cost £
At 01 June 2023 1,956
Additions 1,124
At 31 May 2024 3,080
Depreciation
At 01 June 2023 1,009
Charge for year 489
At 31 May 2024 1,498
Net book value
At 31 May 2024 1,582
At 31 May 2023 947

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

5. Creditors: amounts falling due within one year note

Trade Creditors £88,586 - £104,532 Taxation and Social Securtiy £46,473 - £43,041 Accruals and Deferred Income (£216353) - £3,528 Other Creditors £390,753 - £392,173

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

6. Creditors: amounts falling due after more than one year note

Loans and Borrowings £681,337 - £727,381

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

7. Loans to directors

HYAT PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

8. Related party transactions

Name of the related party: Naser El-Zebdeh
Relationship:
Director
Description of the Transaction: Director Loan to the Company
£
Balance at 01 June 2023 9,692
Balance at 31 May 2024 54
Name of the related party: Amal El-Zebdeh
Relationship:
Director
Description of the Transaction: Director Loan to the Company
£
Balance at 01 June 2023 135,461
Balance at 31 May 2024 269,946
Name of the related party: Mustafa El-Zebdeh
Relationship:
Director
Description of the Transaction: Director Loan to the Company
£
Balance at 01 June 2023 135,461
Balance at 31 May 2024 0